---
title: Dipharma vs Sussex Research Laboratories Inc.
slug_a: dipharma
slug_b: sussex-research
site: cdmo
review_signal_gate: closed
canonical_path: /compare/dipharma/sussex-research
generated_by: BioBM Editorial AI
---

# Dipharma vs Sussex Research Laboratories Inc.

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Dipharma (dipharma) is listed for cdmo. Global CDMO and API manufacturer with 600 employees, 4 cGMP plants, and 75+ years of experience in hazardous chemical synthesis, offering exclusive synthesis services and catalogue APIs with FDA, AIFA, and PMDA inspections since 1970.

Services: 6. Modalities: 1. Indications: 0. Locations: 3. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (6).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Sussex Research Laboratories Inc. (sussex-research) is listed for both. Global leader in carbohydrate and glycan synthesis, offering custom synthesis, CRO, and CDMO services for drug discovery and development. Specializes in GalNAc targeting ligands, glycopeptides, and glycoconjugates with over 25 years of expertise.

Services: 9. Modalities: 4. Indications: 3. Locations: 1. Certifications: 1. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (9).

Review summary: Review summary withheld until site-level review gate opens.